This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.
The combination is currently being considered by European regulatory authorities and if approved GSK plans to sell it as Relvar.
Aside from Breo ( known as Relvar outside the US), Elan will get royalties on sales of COPD combination therapy Anoro ( umeclidinium bromide and vilanterol), vilanterol as a monotherapy and GSK961081, a
Elsewhere, GSK followed up approval in Japan for its respiratory medicine Relvar Ellipta with a CHMP recommendation for use in asthma and COPD, while Plethora Solution's Lidocaine/ Prilocaine Plethora was backed
The Japanese Ministry of Health, Labour and Welfare ( MHLW) cleared GlaxoSmithKline's ( GSK) Relvar Ellipta ( vilanterol and fluticasone), as well as Kyorin Pharmaceutical's Flutiform ( formoterol and fluticasone) for the treatment of bronchial
Adviser questions the drug's cardiovascular profile
In addition to umeclidinium bromide and Anoro, GSK's planned products in respiratory include a combination of fluticasone furoate and vilanterol intended to be marketed as Relvar in Europe and Breo in
More from news
Approximately 2 fully matching, plus 12 partially matching documents found.